DISCOVER is a Marie Sklodowska-Curie and Horizon 2020 project bringing together researchers in the fields of cell death signalling, immunology, protein structural chemistry, drug design, bioinformatics and computational biology in a network that will exchange reagents, technologies and knowledge.

This cross-sectoral network will form a synergistic environment that aims to aid in understanding how the death ligand-death receptor signalling network shapes tumour – immune editing processes. The research programme will lead to better understanding of the evolving role of non-canonical cell death signalling in driving tumour cell motility and invasion and inhibition of tumour immune surveillance.